A CRISPR/Cas9-based galactose screening identifies key mitochondrial genes involved in OXPHOS and oxidative metabolism, highlighting RTN4IP1 and ECHS1 as uncharacterized regulators with potential implications for mitochondrial diseases. This evidence concerns the gene ECHS1 and inborn mitochondrial metabolism disorder.